The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
complicated perhaps but surprisingly all documents appear to be in public domain https://drive.google.com/file/d/1MwOzFUui1znqg9SCj0qzZ3MGZYkOkbn0/view
and the other side of the story (from GLP web site) https://goodlawproject.org/case/abingdon-health/
OilB
Think this covers the gist - something along the lines of allegations of politicians giving government contracts to their mates ! - courtesy abingdon health web site
https://www.abingdonhealth.com/app/uploads/2021/08/2021.05.04-Letter-to-Rook-Irwin-Sweeney-LLP-V5.pdf
Unite
To state (what seems like) the obvious - If SAR hits £5 then they are eligible for FTSE 250 inclusion- £20 and eligible for FTSE inclusion so £10 in that instance is neither here nor there
If everyone hits the sell button then the share price will go down - assuming no-one wants to buy - thats simple market forces - when it reaches bargain levels then equilibrium is restored and it will find its own level (there's always a buyer at a certain level)
MCAP will fluctuate accordingly - but other than that - I don't think there's any real net effect - sure a few fortunes to be made and lost - but as to any specific effect on the company - very little I guess - they still gonna have their assets - raising funds for investment would likely be affected - but assuming by then that they have a steady income stream then they won't need capital raises.
https://www.edisongroup.com/publication/pandemic-disruption-masks-commercial-progress/29826
if they got them all yesterday then about £11.5 million down on the deal !!!
2nd RNS of Today - £45million quid TR1 - losing 25% - if they got them all yesterday then they about £11.5 million down ???!!!
Franklin Templeton Fund Management Limited
5. Date on which the threshold was crossed or reached 11-Aug-2021
6. Date on which Issuer notified 12-Aug-2021
7. Total positions of person(s) subject to the notification obligation
Resulting situation on the date on which threshold was crossed or reached
5.0016% 1,551,675
At these prices I am prepared to go ALL IN !
Think it was mentioned earlier - but my rather simplistic take, in summary, I think that FXPO has had an exceptional run - unfortunately their production levels were actually DOWN and the financial results reflect the extremely high prices for ore that they were receiving.
Further there appear to be worries about China and their future requirements which affects the price of metals. Additionally the "good results" were probably already "baked in" - ie however good they were - they didnt live up to market expectations!
The Divi IMHO is a separate matter - the price will plunge by a corresponding amount when the share goes Ex
Mostly my take and IMHO
35% smudge
https://www.companyformationswitzerland.com/dividend-tax-in-switzerland#:~:text=The%20dividend%20tax%20is%20part%20of%20the%20Swiss,shareholder%20must%20declare%20the%20dividend%20as%20income%20tax.
https://simplywall.st/stocks/gb/pharmaceuticals-biotech/aim-sar/sareum-holdings-shares#ownership
Top 25 shareholders own 55.72% of the company
Ownership Name Shares Current Value Change % Portfolio %
12.05%
HBOS Investment Fund Managers Limited 402,330,641 £34.4m 1.54% 0.3%
8.26%
Barclays Bank PLC, Wealth and Investment Management Division 275,903,697 £23.6m -3.32% 0.24%
4.01%
HSBC Global Asset Management (UK) Limited 133,837,376 £11.4m -0.21% 0.01%
3.83%
A J Bell Holdings Limited, Asset Management Arm 127,981,795 £10.9m 14.34% 0.13%
3.09%
KBC Asset Management NV 103,252,806 £8.8m 10.51% 0.03%
2.94%
Bank Julius Bär & Co Ltd., Asset Management Arm 98,315,000 £8.4m 6.34% 0.04%
2.84%
Equiniti Group Limited, Asset Management Arm 94,723,269 £8.1m 3.76% 0.12%
2.41%
BNP Paribas, Private & Investment Banking Investments 80,350,000 £6.9m 5.52% 0.08%
2.23%
Thesis Asset Management Limited 74,500,000 £6.4m 0% 9.04%
2.14%
Jarvis Securities plc, Asset Management Arm 71,511,711 £6.1m -16.93% 0.29%
1.87%
Deutsche Bank, Private Banking and Investment Banking Investments 62,500,000 £5.3m 0% 0.01%
1.55%
John Reader 51,625,385 £4.4m 0% no data
1.51%
Tim Mitchell 50,476,073 £4.3m 0% no data
1.11%
Charles Stanley & Co. Ltd, Asset Management Arm 36,956,775 £3.2m 31.61% 0.02%
0.85%
Embark Group Limited 28,405,019 £2.4m 0% no data
0.78%
W H Ireland Group plc, Asset Management Arm 26,141,978 £2.2m -6.84% 1.16%
0.75%
IG Group Holdings Plc, Asset Management Arm 24,883,730 £2.1m 25.15% 0.19%
0.65%
UBS Asset Management 21,699,829 £1.9m 20.18% no data
0.54%
Integrated Financial Arrangements plc, Asset Management Arm 18,165,919 £1.6m 17.61% 0.06%
0.46%
Lockwood Advisors, Inc. 15,349,900 £1.3m -5.05% 0.02%
0.41%
Redmayne Bentley LLP, Asset Management Arm 13,791,489 £1.2m 149.79% 0.15%
0.41%
Royal Bank of Canada, Banking & Securities Investments 13,600,000 £1.2m 0.74% no data
0.37%
Brooks Macdonald Asset Management (International) Limited 12,250,000 £1.0m 0% 1.13%
0.33%
Banque Internationale a Luxembourg SA, Asset Management Arm 11,000,000 £940.5k 0% 0.31%
0.33%
Davy Asset Management Limited 11,000,000 £940.5k 57.14% 0.05%
correction Accustem worth around 25p/share
Saints - it really depends on a number of things and the question isn't as simple as it seems
Broadly speaking it is going to depend on your own personal circumstances but depends on
i) how much your Accustem shares are actually worth ( I think they are about 0.25pence/share) so do the math
ii) whether you have US and/or UK shareholdings
If your shareholding in Accustem is worth around £700 or less - it will probably be simply best to get HSBC to sell your shares and credit your HSBC account with the proceeds (indeed this may or may not be their default option if you do nothing ! - I suggest you find out what they propose to do if you indeed "do nothing") - be aware that a number of brokers aren't planning on trading Accustem shares in one or both markets at this time anyway - indeed Trading212 took the easy option with my US allocation there and simply sold them at the earliest opportunity and credited my account - this is likely to be the case with many of the cheap trading brokerages
If your shares are of minimal value then you may ultimately incur dealing charges which will means that it may not really be worth the hassle of holding on to them
I'd probably try to get HSBC to recommend a broker but I doubt they will actually do this ! and also see if they are able to SELL your shares
Please dont take this as financial advice - DYOR - wish you the best whatever decision you make !
Certainly a great backbone for any portfolio - buy and forget :P
I think he meant "both" as in
1 to advance SDC-1801 into clinical development in autoimmune diseases, including the immune overreaction to Covid-19 and other viral infections,
and
2 to progress the preclinical development of our second TYK2/JAK1 inhibitor SDC-1802 against cancers."
I have no idea how this process will work - I see it one of two ways
1. Croft Nominees act in the same way as HL (ie as MY nominee) and they deal direct with me and set an account in my name
or most likely IMO
2. Croft Nominees act as nominee of my nominee (in my case HL) - holding the shares so there's absolutely no possibility of premature sale - they hold all allocation details as received in a sort of stasis - and forward notifications to HL in 9 months - getting a handsome payment for their pains
I don't see any reason that my broker can't indicate on my account of my share-holding at NIL value - we already know we are getting 1 for 2.98 and it would certainly give me peace of mind that my broker is aware - doesn't mean they will !
As for Trading212 - I'm pretty sure they gonna sell on 1st day they can trade them and credit to me about a month later - again that may change.
Either way - it is not my broker who will initially receive any notification from CREST - it will be the nominee (ie CROFT) who will be presumably be performing to instructions provided by OO